RAB17通过抑制TFRC依赖性铁代谢,促进子宫内膜癌的进展
Xing Zhou1, Miaomiao Nie1, Xiaoyan Xin1
1Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, P. R. China.
Cell death & disease
|September 6, 2024
概括
RAB17蛋白质通过阻断细胞死亡过程铁亡,促进子宫内膜癌的进展. 这通过抑制转激素受体表达而发生,特别是在低葡萄糖条件下,有助于瘤存活.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- RAB17蛋白表达与瘤恶性有关,并且在子宫内膜癌 (EC) 组织中升高.
- 在EC进展中RAB17的特定功能和机制尚未完全理解.
研究的目的:
- 研究RAB17在子宫内膜癌进展中的作用.
- 阐明RAB17影响EC的分子机制,特别是关于铁和葡萄糖代谢.
主要方法:
- 西方涂抹和免疫组织化学评估蛋白质表达.
- 在不同的葡萄糖条件下进行细胞培养实验.
- 乌比奎丁-蛋白酶体系统测定.
- 在体外和体外的瘤模型.
- 对临床EC患者数据的分析.
主要成果:
- 通过抑制ferroptosis,RAB17表达显著促进了EC的进展.
- 通过ubiquitin-proteasome通路,RAB17通过降低调节转移林受体 (TFRC) 蛋白表达来抑制铁亡.
- 在低血糖条件下RAB17表达增加,进一步抑制铁亡并通过RAB17-TFRC轴促进EC进展.
- 在体外,体内和临床数据证实RAB17在缺乏葡萄糖的情况下在EC生存中的作用.
结论:
- 通过抑制TFRC依赖性ferroptosis,提高RAB17表达增强了葡萄糖剥夺期间的EC细胞存活率.
- RAB17-TFRC轴代表了管理子宫内膜癌的潜在治疗标,特别是在其缺乏能量的瘤微环境的背景下.
更多相关视频
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.6K
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
12.2K
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
01:15Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K